Found 23 results

[ Author] Title Type Year

Filters: First Letter Of Last Name is O  [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 

O

A. Ouedraogo, Tiono, B. A., Diarra, A., Sanon, S., Yaro, J., Ouédraogo, E., Ouedraogo, A., Konate, T. A., Nebie, I., Watson, N., Sanza, M., Dube, T., Sirima, J., and Sodiomon, B., “Incidence of Clinical Malaria Episodes in a High and Seasonal Malaria Transmission Area of Burkina Faso”, in Malaria Epidemiological Studies (EPI), Bethesda, MD, 2011.

A. V. Osorio, Sullivan, E. K., ,, Bryan, C. F., Shield, C. F., and Warady, B. A., “ABO-mismatched renal transplantation in children: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) and the Midwest Organ Bank (MOB)”, Pediatr Transplantation, vol. 2, pp. 26-29, 1998.

G. Omosa-Manyonyi, Mpendo, J., Ruzagira, E., Kilembe, W., Chomba, E., Roman, F., Bourguignon, P., Koutsoukos, M., Collard, A., Voss, G., Laufer, D., Stevens, G., Hayes, P., Clark, L., Cormier, E., Dally, L., Barin, B., ,, Gilmour, J., Cox, J., Fast, P., and Priddy, F., “A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults”, PLoS One, vol. 10, p. e0125954, 2015.

G. Omosa-Manyonyi, Park, H., Mutua, G., Farah, B., Bergin, P. J., Laufer, D., Lehrman, J., Chinyenze, K., Barin, B., Fast, P., Gilmour, J., and Anzala, O., “Acceptability and Feasibility of Repeated Mucosal Specimen Collection in Clinical Trial Participants in Kenya”, PLoS One, vol. 9, p. e110228, 2014.

C. W. Olanow, Hauser, R. A., Gauger, L., Malapira, T., Koller, W., Hubble, J., Bushenbark, K., Lilienfeld, D., and Esterlitz, J., “The Effect of Deprenyl and Levadopa on the Progression of Parkinson’s Disease”, Ann Neurol, vol. 38, no. 5, pp. 771-777, 1995.

H. Ogutu, Wakasiaka, S., Malogo, R., Ndambuki, R., Nyange, J., Omosa, G., Anzala, O., Bwayo, J., Fast, P., Schmidt, C., Verlinde, C., Smith, C., Ndinya-Achola, J., and Jaoko, W., “Challenges of Use and Compliance With Effective Contraceptives Among Female Participants in Preventive HIV Vaccine Trials: The Kenyan Experience”, in AIDS Vaccine 2007 Conference, Seattle, WA, 2007.

E. A. Oga, Peters, E. N., Mark, K., Trocin, K., and Coleman-Cowger, V. H., “Prenatal Substance Use and Perceptions of Parent and Partner Use Using the 4P's Plus Screener.”, Matern Child Health J, vol. 23, no. 2, pp. 250-257, 2019.

E. A. Oga, Mark, K., Peters, E. N., and Coleman-Cowger, V. H., “Validation of the NIDA-modified ASSIST as a Screening Tool for Prenatal Drug Use in an Urban Setting in the United States.”, J Addict Med, 2020.

K. T. Oen, Thompson, V. P., Vena, D., Caufield, P. W., Curro, F., Dasanayake, A., Ship, J. A., and Lindblad, A., “Attitudes and Expectations of Treating Deep Caries: A PEARL Network Survey”, Gen Dent, vol. 55, pp. 197-203, 2007.

J. Odenkirchen, Ala'i, S., and Esterlitz, J., “A Common Data Language for Clinical Research Studies: The NINDS Common Data Elements”, in American Epilepsy Society Annual Meeting, Seattle, WA, 2014.

J. Odenkirchen, Montoro, M., Ala'i, S., Esterlitz, J., McNeil, E., and Conwit, R., “Public Review: The National Institute of Neurological Disorders and Stroke (NINDS) Congenital Muscular Dystrophy (CMD), Facioscapulohumeral Muscular Dystrophy (FSHD) and Myotonic Dystrophy (DM) Common Data Elements (CDE) Recommendations”, in American Academy of Neurology Annual Meeting, Washington, DC, 2015.

N. Oden and Van Veldhuisen, P., “Interim Monitoring of Non-inferiority Trials”, in Society for Clinical Trials (SCT) 37th Annual Meeting, Montreal, Quebec, Canada, 2016.

N. Oden, Van Veldhuisen, P., Wakim, P., Trivedi, M., Somoza, E., and Lewis, D., “Power of Automated Algorithms for Combining Time-Line Follow-Back and Urine Drug Screening Test Results in Stimulant-Abuse Clinical Trials”, Am J Drug Alcohol Abuse, vol. 37, pp. 350-357, 2011.

N. L. Oden, Lilienfeld, D. E., Lemp, M. A., Nelson, J. D., and Ederer, F., Sensitivity and specificity of a screening questionnaire for dry eye. New York: Plenum Press, 1998.

N. Oden and Sharma, G., “Algorithms for Inference Following Bernoulli Random Walks with Desirable Absorbing Boundaries”, in Society for Clinical Trials Annual Meeting, Boston, MA, 2013.

N. Oden, Van Veldhuisen, P., Scott, I. U., and Ip, M. S., “Closed Testing versus Hochberg's Method for Strongly Controlling Family-Wide Type I Error When Making All Pairwise Comparisons of Means in the SCORE Study”, presented at the 04/2008, St. Louis MO, 2008.

N. Oden, “Adjusting Moran’s I for Population Density”, Stat Med, vol. 14, no. 1, pp. 17-26, 1995.

N. L. Oden, Lindblad, A. S., and Phelps, D., “Interim monitoring in the supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP) study: Design and implementation”, 2000.

N. Oden, Van Veldhuisen, P., Scott, I., and Ip, M., “SCORE Study Report 8: Closed Tests for All Pairwise Comparisons of Means”, Drug Inf J, vol. 44, pp. 405-420, 2010.

N. L. Oden, Lilienfeld, D., and Ederer, F., “Sensitivity with Specificity of a Screening Questionnaire for Dry Eye”, in Second International Conference on the Lacrimose Gland, Tear Film and Dry Eye Syndromes: Basic Social and Clinical Relevance, 1996.

N. Oden and Sharma, G., “Tangency Outcomes for Clinical Trials”, in Society for Clinical Trials 35th Annual Meeting, Philadelphia, PA, 2014.

N. Oden and Kim, J. H., “Bayesian Prediction of Enrollment in Clinical Trials”, 2006.

N. L. Oden and Sullivan, E. K., “Estimating a Mean for Paired and Unpaired Eye Data”, 1996.